BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 63 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,787,760 | +5.2% | 173,378 | +9.2% | 0.00% | 0.0% |
| Q2 2023 | $6,453,072 | +7.2% | 158,786 | +10.5% | 0.00% | 0.0% |
| Q1 2023 | $6,017,124 | -5.2% | 143,744 | -1.3% | 0.00% | 0.0% |
| Q4 2022 | $6,348,675 | +17.7% | 145,679 | +4.8% | 0.00% | 0.0% |
| Q3 2022 | $5,394,000 | -15.0% | 138,952 | -7.1% | 0.00% | 0.0% |
| Q2 2022 | $6,343,000 | -14.6% | 149,594 | -8.3% | 0.00% | 0.0% |
| Q1 2022 | $7,425,000 | -9.9% | 163,105 | -4.0% | 0.00% | 0.0% |
| Q4 2021 | $8,242,000 | +0.6% | 169,935 | -1.2% | 0.00% | 0.0% |
| Q3 2021 | $8,195,000 | -0.9% | 171,985 | +0.9% | 0.00% | 0.0% |
| Q2 2021 | $8,266,000 | +6.8% | 170,440 | +1.9% | 0.00% | 0.0% |
| Q1 2021 | $7,739,000 | -5.7% | 167,327 | -3.0% | 0.00% | 0.0% |
| Q4 2020 | $8,208,000 | +11.0% | 172,465 | -0.0% | 0.00% | 0.0% |
| Q3 2020 | $7,393,000 | +3.5% | 172,469 | -1.5% | 0.00% | 0.0% |
| Q2 2020 | $7,143,000 | +14.4% | 175,130 | +1.1% | 0.00% | 0.0% |
| Q1 2020 | $6,242,000 | -11.1% | 173,148 | +4.9% | 0.00% | 0.0% |
| Q4 2019 | $7,019,000 | +14.0% | 165,133 | +2.6% | 0.00% | 0.0% |
| Q3 2019 | $6,158,000 | -0.5% | 160,997 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $6,190,000 | +8.3% | 159,157 | +10.8% | 0.00% | 0.0% |
| Q1 2019 | $5,718,000 | +5.6% | 143,704 | -3.3% | 0.00% | 0.0% |
| Q4 2018 | $5,416,000 | -30.2% | 148,588 | -18.5% | 0.00% | 0.0% |
| Q3 2018 | $7,755,000 | +5.8% | 182,339 | -4.0% | 0.00% | 0.0% |
| Q2 2018 | $7,329,000 | +7.8% | 189,962 | -2.2% | 0.00% | 0.0% |
| Q1 2018 | $6,796,000 | -75.1% | 194,165 | -74.0% | 0.00% | -80.0% |
| Q4 2017 | $27,292,000 | -1.9% | 747,721 | -2.0% | 0.01% | +25.0% |
| Q3 2017 | $27,811,000 | -3.2% | 762,785 | -2.7% | 0.00% | -33.3% |
| Q2 2017 | $28,742,000 | +2.8% | 784,219 | -3.0% | 0.01% | 0.0% |
| Q1 2017 | $27,959,000 | +9.7% | 808,288 | +0.7% | 0.01% | 0.0% |
| Q4 2016 | $25,478,000 | -10.0% | 802,467 | -2.6% | 0.01% | 0.0% |
| Q3 2016 | $28,319,000 | -5.7% | 824,202 | -2.3% | 0.01% | -14.3% |
| Q2 2016 | $30,044,000 | +0.5% | 843,458 | +0.1% | 0.01% | 0.0% |
| Q1 2016 | $29,893,000 | -10.3% | 843,013 | -0.4% | 0.01% | -12.5% |
| Q4 2015 | $33,315,000 | +0.0% | 846,637 | -4.5% | 0.01% | 0.0% |
| Q3 2015 | $33,312,000 | -13.0% | 886,885 | -0.9% | 0.01% | -33.3% |
| Q2 2015 | $38,299,000 | -2.1% | 894,826 | -1.7% | 0.01% | -7.7% |
| Q1 2015 | $39,130,000 | -11.0% | 910,011 | -11.6% | 0.01% | -18.8% |
| Q4 2014 | $43,969,000 | +10.3% | 1,029,722 | -0.8% | 0.02% | +23.1% |
| Q3 2014 | $39,856,000 | +6.9% | 1,038,455 | +2.3% | 0.01% | +8.3% |
| Q2 2014 | $37,275,000 | +2.9% | 1,014,845 | +3.7% | 0.01% | -7.7% |
| Q1 2014 | $36,215,000 | +5.2% | 978,243 | +0.7% | 0.01% | +8.3% |
| Q4 2013 | $34,416,000 | +0.4% | 971,108 | -7.7% | 0.01% | -14.3% |
| Q3 2013 | $34,282,000 | +3.5% | 1,051,612 | -1.4% | 0.01% | 0.0% |
| Q2 2013 | $33,131,000 | – | 1,066,363 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ahrens Investment Partners LLC | 74,825 | $3,561,000 | 1.91% |
| TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 40,961 | $1,174,000 | 0.99% |
| Diversified, LLC | 19,077 | $818,000 | 0.70% |
| CORRADO ADVISORS, LLC | 9,645 | $459,000 | 0.35% |
| Rikoon Group, LLC | 16,672 | $793,000 | 0.22% |
| Eudaimonia Partners, LLC | 8,240 | $392,000 | 0.09% |
| Arete Wealth Advisors, LLC | 10,658 | $507,000 | 0.07% |
| SOA Wealth Advisors, LLC. | 4,900 | $242,000 | 0.07% |
| Financial Advantage, Inc. | 833 | $39,000 | 0.04% |
| Jacobi Capital Management LLC | 4,184 | $199,000 | 0.03% |